Semmelweis University (SU), the Ministry of Innovation and Technology (MIT) and Novartis Hungary have signed a “first of its kind” Memorandum of Understanding to drive innovation and impact the entire health ecosystem in Hungary. The three pillars of the collaboration are: expand access to and accelerate digitization of clinical research in Hungary, ensure pathway to Hungarian leadership in cell and gene therapies, and launch a “Cardiovascular Intervention Program” aimed at reaching 50k patients in the next 3 years, enabled by artificial intelligence and machine learning and focused on working together to bend the curve of CV disease in Hungary.
28 März 2022
New partnership between Semmelweis University, Ministry of Innovation and Technology, and Novartis takes healthcare innovation in Hungary to a new level
